Education:

• Allan Hancock College, Santa Maria, CA
  A.A., Aeronautical Engineering
• University of California, Santa Barbara, CA
  B.A., Analytical Biology
• California State University, San Diego, CA
  M.S., Biochemistry/Enzymology
• Florida State University, Tallahassee, FL
  Ph.D., Biology/Molecular Genetics
• Univerite Laval, Quebec, P.Q.
  Postdoctoral Fellowship
• Open International University in Complementary Medicine, Colombo, SL
  M.D.( Medicina Alternativa, Honorary)

Current Positions:

• Director
  American Metabolic Laboratories, Hollywood, FL (1996 – present)
• Director
  Metabolic Research, Inc., Hollywood, FL (2002 – present), non-for-profit corporation
• Member, Board of Directors for Florida (2012 – present)
  American Association for Clinical Chemistry, (AACC is an international society comprised of medical professionals with an interest in clinical chemistry, clinical laboratory science, and laboratory medicine)

Past Positions:

• Postdoctoral Fellow, Universite Laval, Quebec City, P.Q., Canada (1 yr)
• Assistant Professor of Biochemistry, Nova University, Fort Lauderdale, FL (5 yrs)
• Nuclear Medicine Technologist, Community Hospital of South Broward, Hallandale, FL (2.5 yrs)
• Chief of Clinical Chemistry and Assistant Laboratory Supervisor, Community Hospital of South Broward (3 yrs)
• Adjunct Professional Staff Member with privileges in Clinical Biochemistry and Supportive and Therapeutic Nutrition:

• 1. Community Hospital of South Broward, Hallandale, FL (15 years)
• 2. Doctors Hospital, Hollywood, FL (15 years)

• Head, Radioimmunoassay and Nutritional Biochemistry, American Biomedical Corporation, Miami, FL (2 yrs)
• Head, Clinical and Special Chemistry and Radioimmunoassay, National Health Laboratories, Miami, FL (1 yr)
• Instructor, Biscayne Paramedical College, Miami, FL (2 yrs)
• Director, Center for Metabolic Disorders, Hollywood, FL (16 yrs)
• Director, CA Laboratories, Dania Beach and Hollywood, FL (14 yrs)
• Scientific Director, Life Extension Foundation, Fort Lauderdale, FL (6 yrs)
• Clinical Laboratory Director, Immuno Laboratories, Inc., Fort Lauderdale, FL (5 yrs)

Licensures and Certifications:

• SC (ASCP): Specialist in Clinical Chemistry, American Society of Clinical Pathology
• CC (NRCC): Clinical Chemist, National Registry in Clinical Chemistry
• LNC: Licensed Nutritional Consultant, State of Florida
• CLD: Clinical Laboratory Director, State of Florida, Clinical Chemistry, Hematology, Serology and Immunohematology
• Clinical Laboratory Director, State of New York
• Clinical Laboratory Director, State of California
• Clinical Laboratory Director/ Technical Director, Department of Health and Human Services

Professional Societies:

• FACB: Fellow, National Academy of Clinical Biochemistry
• ASCP, Member
• American Association of Clinical Chemistry, Member, Board of Directors, Florida
• American College for the Advancement of Medicine, Member

Hobbies:

• Karate: USA GoJu Style, 4° Black Belt, teaching, practicing; competing
• Swimming: 2003 State record holder in 200 yd breaststroke; competing
• SCUBA PADI deep-water certificate
• Private pilot license

Selected peer-reviewed publications (chronological):

• 1) Schandl, E.K., M.S. Thesis: CHARACTERIZATION AND PURIFICATION OF THYMINE 7-HYDROXYLASE, 1967.
• 2) Abbott, M.T., Lin, S., Schandl, E.K., Lee, R.P., T.S. and Midgett, R.J., THE REQUIREMENTS FOR ASCORBATE, Fe and Alpha – KETOGLUTARATE BY THYMINE 7-HYDROXYLASE, 1967. Federation Proc., 26 451.
• 3) Abbott, M.T., Schandl, E.K., Lee, R.P., Parker, T.S. and Midgett, R.J., COFACTOR REQUIREMENTS OF THYMINE 7-HYDROXYLASE, 1967. Biochem. Biophys. Acta, 132-525.
• 4) Taylor J. Herbert, Straubing, Nancy, and Schandl, E.K., UNITS AND PATTERNS OF REPLICATION IN MAMMALIAN CHROMOSOMES, 1968. J. Cell Biol., 39, 1349.
• 5) Schandl, E.K. and Taylor, J. Herbert, AN OLIGOMER INTERMEDIATE (PRIMER) IN DNA REPLICATION, 1969. Biophys. J. 10. 22 (1).
• 6) Schandl, E.K. and Taylor, J. Herbert, EARLY EVENTS IN REPLICATION AND INTEGRATION OF DNA INTO MAMMALIAN CHROMOSOMES, 1969. Biochem. Biophys. Res. Communs., 34 291.
• 7) Schandl, E.K., Ph.D. Dissertation: EARLY EVENTS IN DNA REPLICATION, 1970.
• 8) Schandl, E.K. and Taylor, J. Herbert, OLIGODEOXYRIBONUCLEOTIDES FROM PULSE-LABELED MAMMALIAN CELLS, 1971. Biochim. Biophys. Acta, 228- 595.
• 9) Schandl, E.K., OLIGODEOXYRIBONUCLEOTIDES FROM PULSE LABELED BACTERIAL CELLS, 1972. Biochem. Biophys. Acta, 420 - 430.
• 10) Schandl, E.K., THE USE OF OLIGODEOXYRIBONUCLEOTIDES ISOLATED FROM PULSE-LABELED HeLa IN DNA. SYNTHESIS in vitro, 1972. Cancer Res., 726 - 730.
• 11) Schandl, E.K., THYMINE 7-HYDROXYLASE ACTIVITY IN NORMAL AND LEUKEMIC LEUKOCYTES, 1973. Biochem. Biophys. Res. Communs., 524 - 529.
• 12) Schandl, E.K., STIMULATION OF OLIGODEOXYRIBONUCLEOTIDE SYNTHESIS BY CYTOPLASMIC FACTORS IN THE ISOLATED NUCLEI OF LEUKEMIC CELLS, 1973. Cancer Res. 33 2398 – 2401.
• 13) Mitchell, D.A. and Schandl, E.K., CARBON MONOXIDE, VITAMIN B6 & MULTIPLE SCLEROSIS; A THEORY OF INTERRELATIONSHIP. 1973.Am. J. Clin. Nutr., 26 890.
• 14) Schandl, E.K., HYPERACTIVE CHILDREN, 1973. British Med. J., May 12.
• 15) Schandl, E.K., CLINICAL BIOCHEMICAL PARAMETERS IN CANCER DIAGNOSIS AND THERAPY, 1980. Clinical Chemistry, 26 1040.
• 16) von E.K. Schandl, KLINISH BIOCHEMISCHE PARAMETER BEI KREBS, 1981. In Die Praxis der Zelltherapie, p.98, Medizinish Literarische Verlagsgesellschaft mbh – Uelzen.
• 17) Schandl, M.M., and Schandl, E.K., CEA Testing Abbott or Roche, 1982. Clinical Chemistry, 28 1584.
• 18) von Schandl, in Onkologischer Dialog, Sonntag, 16 Juni 1991. Ed. Dr. Hasso H. Thalmann, Angelos N. Sagredos, Bei Onkologischen Erkrankungen.
• 19) Schandl, Emil K., THE CANCER PROFILE AND ITS CLINICAL APPLICATIONS, Townsend Letter, August/September 2010.
• 20) Schandl, E.K., IGG FOOD ALLERGY TESTING, New England Journal of Medicine, submitted for publication September, 2010.
• 21) Schandl, Emil K., THE CANCER PROFILE AND ITS CLINICAL APPLICATIONS, Anti-Aging Medical News, Spring 2011.

Selected presentations:

• Schandl, E.K. and Schandl, C.A., DHEA-S SERUM LEVEL: CORRELATION TO MALIGNANCIES IN TISSUES OF ECTODERMAL, ENDODERMAL AND MEZODERMAL ORIGIN, 1995. American Association of Anti Aging Medicine Conference, Las Vegas, NV – Poster Presentation
• Schandl, E.K., THE CANCER PROFILE, 2004.American Association of Bioanalysts Educational Conference, Las Vegas, NV - Poster Presentation
• Schandl, E.K., Carlo, Allison, Schandl, C.A., CANCER PROFILE v. CA 15.3, 2006. American Association of Bioanalysts 50th Anniversary Conference, Las Vegas, NV. Award Winning Poster Presentation.
• Schandl, E.K., Carlo, Allison, Schandl, C.A., THE CANCER PROFILE V. CEA TUMOR MARKER IN BREAST CANCER PATIENTS, 2007. American Association of Bioanalysts 51ST Annual meeting and Educational Conference, Orlando, FL.
• Schandl, E.K., Schandl, C.A., CLINICAL BIOCHEMICAL PARAMETERS FOR THE PRACTICE OF PREVENTIVE MEDICINE, 2009. American Society of Clinical Pathologists, Chicago, IL.
• Schandl, E.K., CLINICAL BIOCHEMICAL PARAMETERS FOR THE PRACTICE OF PREVENTIVE MEDICINE, 2010. 18th Annual World Congress on Anti-Aging Medicine and Biomedical Technologies. Las Vegas, NV.
• Schandl, E.K., THE CANCER PROFILE AND LONGEVITY PROFILE, Spring 2011. 19th Annual World Congress on Anti-Aging and Aesthetic Medicine, Orlando, FL.
• Schandl, E.K., THE ROLE OF PHI ENZYME WITHIN THE CANCER PROFILE IN CARCINOGENESIS, Sep. 16th – 18th 2011. Cancer Module III and IV, American Academy of Anti-Aging Medicine, Dallas, TX.
• Schandl, E.K., THE NOVEL ROLE OF PHI ENZYME IN THE CANCER PROFILE AND CARCINOGENESIS, Dec 2011. 19th Annual World Congress on Anti-Aging Medicine and Biomedical Technologies, Las Vegas, NV.
• Schandl, E.K., CLINICAL UTILIZATION OF THE CANCER PROFILE AND LONGEVITY PROFILE AND THE ROLE OF TELOMERASE IN CARCINOGENESIS, Oct 31st - Nov 3rd , 2012. American Society for Clinical Pathology Annual Meeting, Boston, MA - Poster Presentation.
• Schandl, E.K., THE ROLE OF TELOMERASE IN THE CANCER PROFILE AND LONGEVITY PROFILE, Dec 6th, 2012. American Association for Clinical Chemistry, Hollywood, FL.
• Schandl, E.K., CLINICAL UTILIZATON OF THE CANCER PROFILE AND LONGEVITY PROFILE, Dec, 2012. 20th Annual World Congress on Anti-Aging and Regenerative Medicine, Las Vegas, NV.

Awards:

• Schandl, E.K., Carlo, Allison, Schandl, C.A., CANCER PROFILE v. CA 15.3, AWARD WINNING POSTER PRESENTATION, 2006. American Association of Bioanalysts 50th Anniversary Conference, Las Vegas, NV.
• Schandl, E.K., HUMANITARIAN AWARD, 2011. Cancer Control Society 39th Annual Cancer Convention, Universal City, CA.

Research Support:

• National Research Council of Canada: for the investigation of oligodeoxyribonucleotide DNA primer.
• American Cancer Society: for the investigation of oligodeoxyribonucleotide DNA primer.
• Research Grant from a Private Foundation: for PHI enzyme research.

Committee Membership:

• Member, Hon Connie Mack’s (R, FL) U.S. Senatorial Cancer Advisory Committee, 10 years

Consultancy:

• Consultant to Environmental Protection Agency, Toxicology Division, 10 years

Community Service:

• Organizer and Coach, Cooper City/Davie Soccer Club (5 yrs)
• Instructor, karate/self defense and gymnastics, Rainbow Montessori School, Hollywood, FL (11 yrs)
• Newspaper articles on health related subjects (multiple sclerosis, aplastic anemia, drinking water treatment)
• Lectures to cancer support groups, et continuum
• TV and radio show appearances.